Home LiteratureArticle Details
PMID: 21208778 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Validation Study

A combined comorbidity score predicted mortality in elderly patients better than existing scores.

Journal of clinical epidemiology ·Vol. 64 ·No. 7 ·2011-07-00 ·Pages 749-59

Gagne JJ, Glynn RJ, Avorn J, Levin R, Schneeweiss S

Abstract

To develop and validate a single numerical comorbidity score for predicting short- and long-term mortality, by combining conditions in the Charlson and Elixhauser measures. In a cohort of 120,679 Pennsylvania Medicare enrollees with drug coverage through a pharmacy assistance program, we developed a single numerical comorbidity score for predicting 1-year mortality, by combining the conditions in the Charlson and Elixhauser measures. We externally validated the combined score in a cohort of New Jersey Medicare enrollees, by comparing its performance to that of both component scores in predicting 1-year mortality, as well as 180-, 90-, and 30-day mortality. C-statistics from logistic regression models including the combined score were higher than corresponding c-statistics from models including either the Romano implementation of the Charlson Index or the single numerical version of the Elixhauser system; c-statistics were 0.860 (95% confidence interval [CI]: 0.854, 0.866), 0.839 (95% CI: 0.836, 0.849), and 0.836 (95% CI: 0.834, 0.847), respectively, for the 30-day mortality outcome. The combined comorbidity score also yielded positive values for two recently proposed measures of reclassification. In similar populations and data settings, the combined score may offer improvements in comorbidity summarization over existing scores.

MeSH Terms
Aged Cohort Studies Comorbidity Female Hospital Mortality Humans Logistic Models Male Mortality New Jersey/epidemiology Pennsylvania/epidemiology Predictive Value of Tests Risk Adjustment
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Gagne Joshua J
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA. [email protected]
Glynn Robert J
Avorn Jerry
Levin Raisa
Schneeweiss Sebastian
References (26)
26 references, click to expand
  1. Imuunosuppressants, mortality, and risk of cancer.
    BMJ. 2009 Jul 03;339:b1645 PMID: 19578084
  2. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives.
    J Clin Epidemiol. 1993 Oct;46(10):1075-9; discussion 1081-90 PMID: 8410092
  3. Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures.
    Ann Intern Med. 2009 Jun 2;150(11):795-802 PMID: 19487714
  4. A review of uses of health care utilization databases for epidemiologic research on therapeutics.
    J Clin Epidemiol. 2005 Apr;58(4):323-37 PMID: 15862718
  5. Confounder summary scores when comparing the effects of multiple drug exposures.
    Pharmacoepidemiol Drug Saf. 2010 Jan;19(1):2-9 PMID: 19757416
  6. Risk adjustment in outcome assessment: the Charlson comorbidity index.
    Methods Inf Med. 1993 Nov;32(5):382-7 PMID: 8295545
  7. High-dimensional propensity score adjustment in studies of treatment effects using health care claims data.
    Epidemiology. 2009 Jul;20(4):512-22 PMID: 19487948
  8. Comorbidity measures for use with administrative data.
    Med Care. 1998 Jan;36(1):8-27 PMID: 9431328
  9. Assessing the performance of prediction models: a framework for traditional and novel measures.
    Epidemiology. 2010 Jan;21(1):128-38 PMID: 20010215
  10. Comorbidity indices to predict mortality from Medicare data: results from the national registry of atrial fibrillation.
    Med Care. 2005 Nov;43(11):1073-7 PMID: 16224299
  11. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data.
    Med Care. 2009 Jun;47(6):626-33 PMID: 19433995
  12. Improved comorbidity adjustment for predicting mortality in Medicare populations.
    Health Serv Res. 2003 Aug;38(4):1103-20 PMID: 12968819
  13. Use of disease risk scores in pharmacoepidemiologic studies.
    Stat Methods Med Res. 2009 Feb;18(1):67-80 PMID: 18562398
  14. Use and misuse of the receiver operating characteristic curve in risk prediction.
    Circulation. 2007 Feb 20;115(7):928-35 PMID: 17309939
  15. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data.
    Am J Epidemiol. 2001 Nov 1;154(9):854-64 PMID: 11682368
  16. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.
    J Clin Epidemiol. 1992 Jun;45(6):613-9 PMID: 1607900
  17. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.
    Stat Med. 2008 Jan 30;27(2):157-72; discussion 207-12 PMID: 17569110
  18. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.
    J Chronic Dis. 1987;40(5):373-83 PMID: 3558716
  19. The effect of including C-reactive protein in cardiovascular risk prediction models for women.
    Ann Intern Med. 2006 Jul 4;145(1):21-9 PMID: 16818925
  20. Searching for an improved clinical comorbidity index for use with ICD-9-CM administrative data.
    J Clin Epidemiol. 1996 Mar;49(3):273-8 PMID: 8676173
  21. Modeling and variable selection in epidemiologic analysis.
    Am J Public Health. 1989 Mar;79(3):340-9 PMID: 2916724
  22. Data sources for measuring comorbidity: a comparison of hospital records and medicare claims for cancer patients.
    Med Care. 2006 Oct;44(10):921-8 PMID: 17001263
  23. Consistency of performance ranking of comorbidity adjustment scores in Canadian and U.S. utilization data.
    J Gen Intern Med. 2004 May;19(5 Pt 1):444-50 PMID: 15109342
  24. Use of comorbidity scores for control of confounding in studies using administrative databases.
    Int J Epidemiol. 2000 Oct;29(5):891-8 PMID: 11034974
  25. A simulation study of the number of events per variable in logistic regression analysis.
    J Clin Epidemiol. 1996 Dec;49(12):1373-9 PMID: 8970487
  26. Comorbidities, complications, and coding bias. Does the number of diagnosis codes matter in predicting in-hospital mortality?
    JAMA. 1992 Apr 22-29;267(16):2197-203 PMID: 1556797
Article Info
Journal
Journal of clinical epidemiology
Abbr.
J Clin Epidemiol
ISSN
1878-5921
Published
2011-07-00
Epub
2011-00-05
Pages
749-59
Language
English
Region
United States
NLM ID
8801383
PMCID
PMC3100405
Subset
IM
Grants
NLM NIH HHS · R01 LM010213 · United States
NIA NIH HHS · R01 AG018833 · United States
NIA NIH HHS · T32 AG000158 · United States
NIA NIH HHS · R56 AG018833 · United States
NLM NIH HHS · R01-LM10213 · United States
NLM NIH HHS · R01 LM010213-02 · United States
NIA NIH HHS · R01-AG018833 · United States
NIA NIH HHS · T32-AG000158 · United States
NIA NIH HHS · R56 AG018833-04A1 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]